Thakeham

Abingworth strengthens investment team with new appointments in the US and UK

Retrieved on: 
Wednesday, September 15, 2021
Neurology, Investment, Peking University, University, CA, Partner, Private equity, Bachelor of Science, ZS Associates, McKinsey & Company, Doctor of Philosophy, Neuroscience, Bachelor of Medicine, Bachelor of Surgery, ZS, Medicine, European Pharmaceutical Students' Association, Principal, List of life sciences, National Hospital for Neurology and Neurosurgery, Consultant, Clinical Neuropharmacology, Imperial College London, Campbell Alliance, UCLH, MBA, L.E.K. Consulting, Thakeham, University College London, Chicago (franchise), Management, Pharmaceutical industry

LONDON, Sept. 15, 2021 /PRNewswire/ --Abingworth, a leading international life sciences investment group, announces three new appointments to its investment team in the UK and US.

Key Points: 
  • LONDON, Sept. 15, 2021 /PRNewswire/ --Abingworth, a leading international life sciences investment group, announces three new appointments to its investment team in the UK and US.
  • Jay will be based at the firm's Menlo Park, CA office and Lucille and Diya will be based in London, UK.
  • ABV 8 Abingworth Bioventures 8; ACCD2 Abingworth Clinical Co-Development Fund 2
    Abingworth is a leading transatlantic life sciences investment firm.
  • Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston

Abingworth strengthens investment team with new appointments in the US and UK

Retrieved on: 
Wednesday, September 15, 2021
Neurology, Investment, Peking University, University, CA, Partner, Private equity, Bachelor of Science, ZS Associates, McKinsey & Company, Doctor of Philosophy, Neuroscience, Bachelor of Medicine, Bachelor of Surgery, ZS, Medicine, European Pharmaceutical Students' Association, Principal, List of life sciences, National Hospital for Neurology and Neurosurgery, Consultant, Clinical Neuropharmacology, Imperial College London, Campbell Alliance, UCLH, MBA, L.E.K. Consulting, Thakeham, University College London, Chicago (franchise), Management, Pharmaceutical industry

LONDON, Sept. 15, 2021 /PRNewswire/ --Abingworth, a leading international life sciences investment group, announces three new appointments to its investment team in the UK and US.

Key Points: 
  • LONDON, Sept. 15, 2021 /PRNewswire/ --Abingworth, a leading international life sciences investment group, announces three new appointments to its investment team in the UK and US.
  • Jay will be based at the firm's Menlo Park, CA office and Lucille and Diya will be based in London, UK.
  • ABV 8 Abingworth Bioventures 8; ACCD2 Abingworth Clinical Co-Development Fund 2
    Abingworth is a leading transatlantic life sciences investment firm.
  • Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston

Abingworth raises $465m for new life sciences fund Abingworth Bioventures 8

Retrieved on: 
Wednesday, February 3, 2021
Abingworth, Finance, Money, Thakeham, Venture capital, Financial economics

LONDON, Feb. 3, 2021 /PRNewswire/ -- Abingworth, a leading international life sciences investment group, today announced the final closing of its latest transatlantic venture fund, Abingworth Bioventures 8 (ABV 8) at $465 million.

Key Points: 
  • LONDON, Feb. 3, 2021 /PRNewswire/ -- Abingworth, a leading international life sciences investment group, today announced the final closing of its latest transatlantic venture fund, Abingworth Bioventures 8 (ABV 8) at $465 million.
  • ABV 8, which is Abingworth's 13th life sciences fund, exceeded its target of $375 million and closed at its hard cap.
  • "Abingworth has a long and successful track record investing in the life sciences sector in the US and in the UK and Europe.
  • Since 1973, Abingworth has invested in 170 life science companies, leading to 44 M&As and 69 IPOs.

Abingworth promotes Bali Muralidhar to Managing Partner

Retrieved on: 
Monday, December 21, 2020
Abingworth, Bain Capital, Thakeham

LONDON, Dec. 21, 2020 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, is pleased to announce the promotion of Bali Muralidhar MD PhD to Managing Partner, further strengthening the senior management of the firm.Bali is joining Tim Haines, Genghis Lloyd-Harris and Kurt von Emster in the Managing Partner role at the firm.

Key Points: 
  • LONDON, Dec. 21, 2020 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, is pleased to announce the promotion of Bali Muralidhar MD PhD to Managing Partner, further strengthening the senior management of the firm.Bali is joining Tim Haines, Genghis Lloyd-Harris and Kurt von Emster in the Managing Partner role at the firm.
  • Tim Haines, Chairman & Managing Partner, said: "Bali is an extremely talented investor who, since joining Abingworth, has brought new ideas that have made a significant and positive contribution to how we operate as a firm.
  • Bali joined Abingworth as a Partner in April 2019, bringing more than 15 years of experience in the healthcare sector, including as a Senior Partner at MVM Partners LLP and as a member of Bain Capital's healthcare deal team.
  • Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston.

Abingworth promotes Bali Muralidhar to Managing Partner

Retrieved on: 
Monday, December 21, 2020
Abingworth, Bain Capital, Thakeham

LONDON, Dec. 21, 2020 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, is pleased to announce the promotion of Bali Muralidhar MD PhD to Managing Partner, further strengthening the senior management of the firm.Bali is joining Tim Haines, Genghis Lloyd-Harris and Kurt von Emster in the Managing Partner role at the firm.

Key Points: 
  • LONDON, Dec. 21, 2020 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, is pleased to announce the promotion of Bali Muralidhar MD PhD to Managing Partner, further strengthening the senior management of the firm.Bali is joining Tim Haines, Genghis Lloyd-Harris and Kurt von Emster in the Managing Partner role at the firm.
  • Tim Haines, Chairman & Managing Partner, said: "Bali is an extremely talented investor who, since joining Abingworth, has brought new ideas that have made a significant and positive contribution to how we operate as a firm.
  • Bali joined Abingworth as a Partner in April 2019, bringing more than 15 years of experience in the healthcare sector, including as a Senior Partner at MVM Partners LLP and as a member of Bain Capital's healthcare deal team.
  • Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston.

Abingworth Appoints Bali Muralidhar as Partner

Retrieved on: 
Tuesday, March 26, 2019
Abingworth, Bali, Thakeham, Southeast Asia, Geography of Asia

LONDON, March 26, 2019 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, today announced the appointment of Bali Muralidhar as a Partner based in the London office.

Key Points: 
  • LONDON, March 26, 2019 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, today announced the appointment of Bali Muralidhar as a Partner based in the London office.
  • Prior to joining Abingworth, Bali was a senior partner at MVM Partners LLP in London where he completed investments in and served on the boards of several companies, both public and private.
  • Tim Haines, Managing Partner, said: "I am delighted to welcome Bali to the Abingworth team.
  • I am very much looking forward to bringing my experience to the team,"added Bali Muralidhar.

Abingworth Appoints Bali Muralidhar as Partner

Retrieved on: 
Tuesday, March 26, 2019
Abingworth, Bali, Thakeham, Southeast Asia, Geography of Asia

LONDON, March 26, 2019 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, today announced the appointment of Bali Muralidhar as a Partner based in the London office.

Key Points: 
  • LONDON, March 26, 2019 /PRNewswire/ -- Abingworth, the international investment group dedicated to life sciences, today announced the appointment of Bali Muralidhar as a Partner based in the London office.
  • Prior to joining Abingworth, Bali was a senior partner at MVM Partners LLP in London where he completed investments in and served on the boards of several companies, both public and private.
  • Tim Haines, Managing Partner, said: "I am delighted to welcome Bali to the Abingworth team.
  • I am very much looking forward to bringing my experience to the team,"added Bali Muralidhar.